Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

Launched by NEUROBEHAVIORAL SYSTEMS, INC. · Mar 12, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how well healthy individuals of various ages can perform on new computerized tests designed to measure thinking and memory skills. The goal is to gather important information that can help identify people who may be at risk for cognitive decline, which is a common issue as we age and can be an early sign of Alzheimer's disease.

To participate in this study, you need to be between the ages of 65 and 74, able to use a computer mouse and touch screen, and speak either English or Spanish. However, there are some health-related reasons that might exclude you from joining, such as having a history of certain psychiatric or medical conditions. If you decide to participate, you will complete a series of computerized tasks that assess your thinking abilities. This research could play a vital role in understanding early signs of cognitive decline and ultimately help improve care for those at risk.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Must be able to use computer mouse and touch screen
• • Must speak English as a primary language
• • Must speak Spanish as a primary language (for Latino participants completing our Spanish translation)
• Exclusion Criteria:
• • History of psychiatric disorder
• • History of stroke or transient ischemic attack
• • History of substance abuse
• • History of medical or sensory disorders that are incompatible with effective testing
• • History of traumatic brain injury with hospitalization and extended loss of consciousness
• • History of epilepsy
• • History of depression or anxiety